Nearly 50 patients per months are tested at Nanjing Medical Technology Innovation Center to achieve individualized medical treatment

The Center, operated by Southern Medical University and the District Government, is targeting genes related to breast, lung, prostate and ovarian cancers, followed by a patient-specific use of antitumor drugs.

China Bio news release, October 13, 2014

Most popular posts: